{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:32:29Z","timestamp":1791952349938,"version":"4.3.4"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/qai.0b013e3181a254c2","type":"journal-article","created":{"date-parts":[[2009,7,6]],"date-time":"2009-07-06T03:29:49Z","timestamp":1246850989000},"page":"486-491","source":"Crossref","is-referenced-by-count":23,"title":["Prevalence, Risk Factors, and Impact on Outcome of Cytomegalovirus Replication in Serum of Cambodian HIV-Infected Patients (2004-2007)"],"prefix":"10.1097","volume":"51","author":[{"given":"Romain","family":"Micol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Buchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Guerrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veasna","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Ferradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Dousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe J","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suna","family":"Balkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Galimand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak","family":"Chanroeun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rouzioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Fontanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Leruez-Ville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210131","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI1101","article-title":"Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.","volume":"101","author":"Spector","year":"1998","journal-title":"J Clin Invest"},{"key":"R2-17-20210131","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.qai.0000155204.96973.c3","article-title":"Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies.","volume":"38","author":"Wohl","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-17-20210131","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(04)16500-8","article-title":"Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy.","volume":"363","author":"Deayton","year":"2004","journal-title":"Lancet"},{"key":"R4-17-20210131","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0213-005X(04)73054-2","article-title":"[Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy].","volume":"22","author":"Reus","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R5-17-20210131","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QAI.0b013e31811ed32c","article-title":"Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.","volume":"45","author":"Micol","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-17-20210131","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R7-17-20210131","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JCM.41.5.2040-2046.2003","article-title":"Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma.","volume":"41","author":"Leruez-Ville","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R8-17-20210131","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00002030-199707000-00008","article-title":"Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease.","volume":"11","author":"Bowen","year":"1997","journal-title":"AIDS"},{"issue":"Suppl 1","key":"R9-17-20210131","first-page":"180","article-title":"Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors.","volume":"24","author":"Urwijitaroon","year":"1993","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R10-17-20210131","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/170.5.1271","article-title":"Detection of cytomegalovirus DNA in serum correlates with clinical cytomegalovirus retinitis in AIDS.","volume":"170","author":"Hansen","year":"1994","journal-title":"J Infect Dis"},{"key":"R11-17-20210131","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1086\/340651","article-title":"Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease.","volume":"185","author":"Nokta","year":"2002","journal-title":"J Infect Dis"},{"key":"R12-17-20210131","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0008-4182(04)80067-X","article-title":"Laboratory-based risk factors for cytomegalovirus retinitis.","volume":"39","author":"Hodge","year":"2004","journal-title":"Can J Ophthalmol"},{"key":"R13-17-20210131","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood.V75.10.1965.1965","article-title":"Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus.","volume":"75","author":"Sing","year":"1990","journal-title":"Blood"},{"key":"R14-17-20210131","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1743-422X-5-47","article-title":"Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review.","volume":"5","author":"Rafailidis","year":"2008","journal-title":"Virol J"},{"key":"R15-17-20210131","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1371\/journal.pmed.0040334","article-title":"Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic.","volume":"4","author":"Heiden","year":"2007","journal-title":"PLoS Med"},{"key":"R16-17-20210131","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-1293.2000.00012.x","article-title":"Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.","volume":"1","author":"French","year":"2000","journal-title":"HIV Med"},{"key":"R17-17-20210131","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1086\/314639","article-title":"Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy.","volume":"179","author":"Karavellas","year":"1999","journal-title":"J Infect Dis"},{"key":"R18-17-20210131","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/01.aids.0000166100.36638.97","article-title":"Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy.","volume":"19","author":"Ortega-Larrocea","year":"2005","journal-title":"AIDS"},{"key":"R19-17-20210131","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1310\/4J65-4YX1-4ET6-E5KR","article-title":"The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.","volume":"6","author":"Wohl","year":"2005","journal-title":"HIV Clin Trials"},{"key":"R20-17-20210131","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa011759","article-title":"A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.","volume":"346","author":"Martin","year":"2002","journal-title":"N Engl J Med"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-200908010-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:52:17Z","timestamp":1786038737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200908010-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181a254c2","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}